enquiry@dsij.in |+91 9240904920
SENSEX-537.54
77,471.71-0.69%

Divi's Laboratories Ltd.

(Industry - Pharmaceuticals & Drugs)

8,495.5

-4.50 (-0.05%)

Today High/Low

L
H
8,482.058,599.95

52 Week High/Low

L
H
5,687.58,545

About Company

Divi's Laboratories Limited manufactures active pharmaceutical ingredients, intermediates and nutraceutical ingredients for business-to-business customers in the pharmaceutical supply chain. Its portfolio includes generic APIs and intermediates, nutraceutical ingredients, and custom synthesis services for innovator pharmaceutical companies, spanning clinical-trial supplies, product launches and life-cycle management. The company operates three manufacturing facilities and an R&D centre in India, including a Kakinada unit, and has marketing subsidiaries in the United States and Switzerland. Its business is predominantly export-oriented.

Market Cap.
₹2,25,528.83 Cr.
P/E Ratio
67.35
P/B Ratio
11.79
Current Price
₹8,495.5
Open
₹8,599.95
High
₹8,599.95
Prev Close
₹8,500
Quantity Traded
15,457
52 Week High
₹8,545
52 Week Low
₹5,687.5
Dividend Yield
0.4%
EBITDA Margin
37.83%
ROE
17.45%
Book Value
₹629.49
Face Value
₹2
MindshareMutual FundQuarterly ResultsInterviewsIPO AnalysisMultibaggerPenny StocksDividendBonus & Stock SplitSMEPersonal FinanceSwing Trading

If you want to stay updated with the Share Market News Today, keep a close watch on the Indian Stock Market Today with real time movements like Sensex Today Live and overall trends. Investors tracking IPO Allotment Status, IPO News Today, or the Latest IPO India can also follow daily updates along with BSE Share Price Live data. Whether you are learning How To Invest in Stock Market in India, preparing for a Market Crash Today, or searching for the Best Stocks to Buy in India, insights on Top Gainers Today India, Top Losers Today India, Trending Stocks India and Long Term Stocks India help in making informed investment decisions.

Stay informed, stay disciplined, and make smarter investment choices with timely and reliable market insights.